Last updated on September 2018

A Study Comparing Efficacy of Levodopa-Carbidopa Intestinal Gel/Carbidopa-Levodopa Enteral Suspension and Optimized Medical Treatment on Dyskinesia in Subjects With Advanced Parkinson's Disease (DYSCOVER)


Brief description of study

The primary objective of this study is to examine the effect of levodopa-carbidopa intestinal gel (LCIG) compared with optimized medical treatment (OMT) on dyskinesia in participants with advanced Parkinson's disease (PD).

Clinical Study Identifier: NCT02799381

Contact Investigators or Research Sites near you

Start Over

ABBVIE CALL CENTER

Hospital Universitario Infanta /ID# 159696
Madrid, Spain
  Connect »

ABBVIE CALL CENTER

Hospital Univ Ramon y Cajal /ID# 150152
Madrid, Spain
6.95miles
  Connect »